Science Explorer Back to mapMap
Discussion
Company · Chiba · Japan

Yamasa Corporation (Japan)

In research, Yamasa Corporation (Japan) stands highest in Biochemistry, Genetics and Molecular Biology (#5,572 of 5,801 worldwide) and Life Sciences (#10,709 of 11,023 worldwide), over all time.

World rank, all time
#34,483
of 34,923
Rank in Japan
#1,873
of 1,923
Research works
394
▲ 81% vs 2018-21
Citations
7.6k
19.2 per fractional work
Top-10% rate
1.3%
all institutions 10.0%
vs its own fields
0.71×
1.00× is exactly expected
Open access
40%
world 40%
International
5%
world 18%

What is Yamasa Corporation (Japan) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Biochemistry, Genetics and Molecular BiologyField #5,572 of 5,801 3.1%161
Life SciencesDomain #10,709 of 11,023 3.6%218

Each strip is that field's whole ranked pool, with the notch where Yamasa Corporation (Japan) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Yamasa Corporation (Japan) work in?

In all years, 55% of research at Yamasa Corporation (Japan) is in Life Sciences, 29% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (41%), Medicine (26%), Chemistry (7%). It does 3.5× the world's share of Life Sciences.

Life Sciences: 218 fractional works · 55.4% of its workBiochemistry, Genetics and Molecular Biology: 161 fractional works · 40.8% of its workMolecular Biology: 118 fractional works · 30.0% of its workBiotechnology: 13 fractional works · 3.3% of its workGenetics: 9 fractional works · 2.3% of its workPhysiology: 7 fractional works · 1.9% of its workBiochemistry: 7 fractional works · 1.7% of its workCell Biology: 3 fractional works · 0.7% of its workClinical Biochemistry: 2 fractional works · 0.5% of its workSmaller subfields together: 1 fractional works · 0.3% of its workAgricultural and Biological Sciences: 28 fractional works · 7.2% of its workPlant Science: 14 fractional works · 3.6% of its workFood Science: 11 fractional works · 2.7% of its workEcology, Evolution, Behavior and Systematics: 1 fractional works · 0.4% of its workAnimal Science and Zoology: 1 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.2% of its workNeuroscience: 13 fractional works · 3.4% of its workCellular and Molecular Neuroscience: 8 fractional works · 2.0% of its workNeurology: 2 fractional works · 0.4% of its workSensory Systems: 1 fractional works · 0.3% of its workBiological Psychiatry: 1 fractional works · 0.3% of its workSmaller subfields together: 2 fractional works · 0.4% of its workImmunology and Microbiology: 12 fractional works · 3.1% of its workImmunology: 10 fractional works · 2.6% of its workVirology: 2 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.0% of its workPharmacology, Toxicology and Pharmaceutics: 4 fractional works · 1.0% of its workPharmaceutical Science: 2 fractional works · 0.4% of its workToxicology: 1 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.2% of its workHealth Sciences: 112 fractional works · 28.6% of its workMedicine: 104 fractional works · 26.5% of its workEpidemiology: 19 fractional works · 4.9% of its workInfectious Diseases: 13 fractional works · 3.4% of its workPharmacology: 10 fractional works · 2.5% of its workOncology: 9 fractional works · 2.4% of its workEndocrinology, Diabetes and Metabolism: 6 fractional works · 1.5% of its workRadiology, Nuclear Medicine and Imaging: 6 fractional works · 1.5% of its workCardiology and Cardiovascular Medicine: 6 fractional works · 1.5% of its workPhysiology: 5 fractional works · 1.3% of its workPulmonary and Respiratory Medicine: 4 fractional works · 1.1% of its workRheumatology: 4 fractional works · 1.0% of its workPathology and Forensic Medicine: 3 fractional works · 0.8% of its workSurgery: 2 fractional works · 0.6% of its workHematology: 2 fractional works · 0.4% of its workGenetics: 1 fractional works · 0.4% of its workDermatology: 1 fractional works · 0.3% of its workImmunology and Allergy: 1 fractional works · 0.3% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 0.3% of its workBiochemistry: 1 fractional works · 0.3% of its workHepatology: 1 fractional works · 0.3% of its workNephrology: 1 fractional works · 0.2% of its workReproductive Medicine: 1 fractional works · 0.2% of its workAnesthesiology and Pain Medicine: 1 fractional works · 0.2% of its workSmaller subfields together: 4 fractional works · 1.0% of its workNursing: 8 fractional works · 2.1% of its workNutrition and Dietetics: 8 fractional works · 2.1% of its workPhysical Sciences: 58 fractional works · 14.8% of its workChemistry: 29 fractional works · 7.4% of its workOrganic Chemistry: 26 fractional works · 6.7% of its workSpectroscopy: 1 fractional works · 0.3% of its workAnalytical Chemistry: 1 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.1% of its workEngineering: 15 fractional works · 3.8% of its workBiomedical Engineering: 4 fractional works · 0.9% of its workElectrical and Electronic Engineering: 2 fractional works · 0.5% of its workCivil and Structural Engineering: 2 fractional works · 0.4% of its workMechanical Engineering: 2 fractional works · 0.4% of its workAerospace Engineering: 2 fractional works · 0.4% of its workMechanics of Materials: 1 fractional works · 0.3% of its workSafety, Risk, Reliability and Quality: 1 fractional works · 0.3% of its workComputational Mechanics: 1 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.3% of its workEnvironmental Science: 7 fractional works · 1.7% of its workEcology: 4 fractional works · 0.9% of its workHealth, Toxicology and Mutagenesis: 2 fractional works · 0.4% of its workSmaller subfields together: 2 fractional works · 0.4% of its workMaterials Science: 4 fractional works · 1.0% of its workMaterials Chemistry: 3 fractional works · 0.7% of its workSmaller subfields together: 1 fractional works · 0.4% of its workChemical Engineering: 1 fractional works · 0.3% of its workBioengineering: 1 fractional works · 0.3% of its workComputer Science: 1 fractional works · 0.2% of its workEnergy: 0 fractional works · 0.1% of its workEarth and Planetary Sciences: 0 fractional works · 0.1% of its workPhysics and Astronomy: 0 fractional works · 0.0% of its workSocial Sciences: 5 fractional works · 1.3% of its workSocial Sciences: 2 fractional works · 0.6% of its workSociology and Political Science: 1 fractional works · 0.3% of its workTransportation: 1 fractional works · 0.3% of its workPsychology: 1 fractional works · 0.3% of its workSocial Psychology: 1 fractional works · 0.3% of its workEconomics, Econometrics and Finance: 1 fractional works · 0.3% of its workDecision Sciences: 0 fractional works · 0.0% of its workArts and Humanities: 0 fractional works · 0.0% of its workALL ITS WORKYamasaCorporation…394fractional works, all years
Life Sciences55%Physical Sciences15%Health Sciences29%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 22 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology16140.8%
    2. Agricultural and Biological Sciences287.2%
    3. Neuroscience133.4%
    4. Immunology and Microbiology123.1%
    5. Pharmacology, Toxicology and Pharmaceutics41.0%
    1. Medicine10426.5%
    2. Nursing82.1%
    3. Health Professions00.0%
    1. Chemistry297.4%
    2. Engineering153.8%
    3. Environmental Science71.7%
    4. Materials Science41.0%
    5. Chemical Engineering10.3%
    6. Computer Science10.2%
    7. Energy00.1%
    8. Earth and Planetary Sciences00.1%
    9. Physics and Astronomy00.0%
    1. Social Sciences20.6%
    2. Psychology10.3%
    3. Economics, Econometrics and Finance10.3%
    4. Decision Sciences00.0%
    5. Arts and Humanities00.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.97× its world share, 2 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 6.13× its world share, 6 worksBiochemistry, Geneti…Immunology and Microbiology: 6.35× its world share, 1 worksImmunology and Micro…Neuroscience: 1.19× its world share, 0 worksNeuroscienceChemistry: 0.34× its world share, 0 worksChemistryComputer Science: 0.33× its world share, 0 worksComputer ScienceEnergy: 0.70× its world share, 0 worksEnergyEngineering: 0.88× its world share, 2 worksEngineeringEnvironmental Science: 1.17× its world share, 1 worksEnvironmental ScienceMaterials Science: 1.25× its world share, 1 worksMaterials ScienceHealth Professions: 0.12× its world share, 0 worksHealth ProfessionsMedicine: 1.00× its world share, 3 worksMedicineArts and Humanities: 0.22× its world share, 0 worksArts and HumanitiesDecision Sciences: 1.00× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.15× its world share, 0 worksEconomics, Econometr…Psychology: 0.21× its world share, 0 worksPsychologySocial Sciences: 0.03× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.3×. Every wedge is a field page.

All 17 fields, with their numbers
  1. Immunology and Microbiology6.35×1 works
  2. Biochemistry, Genetics and Molecular Biology6.13×6 works
  3. Agricultural and Biological Sciences1.97×2 works
  4. Materials Science1.25×1 works
  5. Neuroscience1.19×0 works
  6. Environmental Science1.17×1 works
  7. Medicine1.00×3 works
  8. Decision Sciences1.00×0 works
  9. Engineering0.88×2 works
  10. Energy0.70×0 works
  11. Chemistry0.34×0 works
  12. Computer Science0.33×0 works
  13. Arts and Humanities0.22×0 works
  14. Psychology0.21×0 works
  15. Economics, Econometrics and Finance0.15×0 works
  16. Health Professions0.12×0 works
  17. Social Sciences0.03×0 works

Who are the top researchers at Yamasa Corporation (Japan)?

Ranked on the quality score, Kazuya Ishige, Kenji Kitano and Yohko Watanabe lead among researchers whose main affiliation is Yamasa Corporation (Japan).

  1. 1 Kazuya Ishige Japan · #2,612,441 worldwide 1.2k citations · 21 works
  2. 2 Kenji Kitano Japan · #3,850,331 worldwide 737 citations · 19 works
  3. 3 Yohko Watanabe Japan · #4,095,485 worldwide 689 citations · 21 works
  4. 4 Masaru Hamaoki Japan · #4,471,297 worldwide 842 citations · 24 works
  5. 5 Toichi Abiru Japan · #5,152,252 worldwide 723 citations · 27 works
  6. 6 Junichi Takezawa Japan · #5,268,696 worldwide 769 citations · 17 works
  7. 7 A Matsuda Japan · #5,462,267 worldwide 134 citations · 21 works
  8. 8 Katsushi Ijichi Japan · #5,806,009 worldwide 280 citations · 16 works
  9. 9 Noriyuki Ashida Japan · #5,842,217 worldwide 1.2k citations · 68 works
  10. 10 Yoshinobu Mogi Japan · #5,891,937 worldwide 453 citations · 22 works
All ranked researchers at Yamasa Corporation (Japan)

What are the most cited papers from Yamasa Corporation (Japan)?

The most cited paper from Yamasa Corporation (Japan) is "Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease" (Eiji Matsuura, Yoshiko Igarashi, Masao Fujimoto et al., 1990), with 729 citations. Next come "An ultrasensitive method for the simultaneous determination of cyclic AMP and cyclic GMP in small-volume samples from blood and tissue" (677) and "Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface." (532).

Most cited papers
#PaperReleasedCitations
1 Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease Eiji Matsuura, Yoshiko Igarashi, Masao Fujimoto et al. · The Lancet Jul 1990 729
2 An ultrasensitive method for the simultaneous determination of cyclic AMP and cyclic GMP in small-volume samples from blood and tissue Miyuki Honma, Tomokazu Satoh, Junichi Takezawa et al. · Biochemical Medicine Dec 1977 677
3 Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. Eiji Matsuura, Yoshiko Igarashi, Tatsuji Yasuda et al. · The Journal of Experimental Medicine Open access Feb 1994 532
4 Serial Changes in Surfactant-associated Proteins in Lung and Serum before and after Onset of ARDS Kelly E. Greene, Jo Rae Wright, Kenneth P. Steinberg et al. · American Journal of Respiratory and Critical Care Medicine Dec 1999 421
5 Transforming growth factor-β stimulates the expression of endothelin mRNA by vascular endothelial cells Hiroki Kurihara, Masao Yoshizumi, Takao Sugiyama et al. · Biochemical and Biophysical Research Communications Mar 1989 419
All 58 most cited papers, with filters and sorting

Which keywords describe research at Yamasa Corporation (Japan)?

By fractional works in all years, weighted toward what it does more of than the world: Therapeutic Targets, Enzyme Regulation, Nucleotide Metabolism, Synthesis, Genomic Stability, DNA Structure, G-Quadruplexes and Cancer.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Therapeutic Targets26▲ 28×5 topics
  2. Inflammation25▲ 2.7×40 topics
  3. Cancer23▲ 4.1×14 topics
  4. Enzyme Regulation20▲ 102×1 topic
  5. Nucleotide Metabolism20▲ 142×1 topic
  6. Synthesis19▲ 8.4×12 topics
  7. Genomic Stability19▲ 51×2 topics
  8. DNA Structure17▲ 71×1 topic
  9. G-Quadruplexes17▲ 71×1 topic
  10. Drug Discovery17▲ 11×8 topics
  11. Fermentation16▲ 28×4 topics
  12. Antiretroviral Therapy15▲ 17×5 topics
  13. Cancer Therapy14▲ 5.7×12 topics
  14. Immune Response13▲ 5.5×15 topics
  15. Metabolism13▲ 5.3×13 topics
  16. Signal Transduction13▲ 13×6 topics
  17. Viral Diseases12▲ 36×2 topics
  18. Drug Resistance12▲ 9.7×2 topics
  19. Adverse Effects12▲ 38×2 topics
  20. HIV Infection12▲ 24×2 topics
  21. Integrase Inhibitors12▲ 72×1 topic
  22. Nucleoside Analogues12▲ 72×1 topic
  23. Tumor Microenvironment11▲ 8.2×3 topics
  24. Glycosidase Inhibitors11▲ 55×1 topic
  25. Oligosaccharide Synthesis11▲ 55×1 topic
  26. Gene Expression11▲ 4.5×7 topics
  27. Neuroprotection11▲ 7.3×9 topics
  28. Vaccine11▲ 6.8×5 topics
  29. Antimicrobial Activity11▲ 14×5 topics
  30. Antioxidant Activity10▲ 4.8×9 topics
  31. Biosynthesis10▲ 19×5 topics
  32. Gene Therapy10▲ 10×5 topics
  33. Genomics10▲ 7.6×6 topics
  34. Glycosylation10▲ 12×3 topics
  35. Anticancer Agents10▲ 9.5×7 topics
  36. Biogenic Amines9▲ 36×2 topics
  37. Neurotransmitters9▲ 33×2 topics
  38. Biological Evaluation8▲ 17×4 topics
  39. Herpes Zoster8▲ 47×1 topic
  40. Herpesviruses8▲ 47×1 topic

Which research topics does Yamasa Corporation (Japan) publish most on?

By volume in 2022-now: Culinary Culture and Tourism, Muscle Physiology and Disorders, Urban and spatial planning and Exercise and Physiological Responses.

  1. 1 Culinary Culture and Tourism Food Science 1 works
  2. 2 Muscle Physiology and Disorders Molecular Biology 1 works
  3. 3 Urban and spatial planning Nature and Landscape Conservation 0 works
  4. 4 Exercise and Physiological Responses Rehabilitation 0 works
  5. 5 Enzyme Production and Characterization Biotechnology 0 works
  6. 6 Immune Cell Function and Interaction Immunology 0 works
  7. 7 Genomics and Phylogenetic Studies Molecular Biology 0 works
  8. 8 Bacteriophages and microbial interactions Ecology 0 works
  9. 9 RNA and protein synthesis mechanisms Molecular Biology 0 works
  10. 10 Bone and Dental Protein Studies Rheumatology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available39.9%not open60.1%

World: 40% of research is openly available.

with international co-authors5.3%domestic only94.7%

World: 18% is written across borders.

How has Yamasa Corporation (Japan)'s research output changed?

Output in 2022-2025 was 81% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Yamasa Corporation (Japan) as a percentage of every work published that year, 0.000094% in 2024.

still counting0.0020%0.0040%0.0060%Yamasa Corporation (Japan)0.000021% in 202519801990200020102020

Fractional works of Yamasa Corporation (Japan) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Chiba

All research institutions in Chiba

Share Yamasa Corporation (Japan)'s ranking

Yamasa Corporation (Japan) on Science Explorer

A card with Yamasa Corporation (Japan)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Yamasa Corporation (Japan). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.